The total CD4+ T cell component was substantially similar in PD and CD patients irrespectively of the tumor/stroma location; therefore, the CD8/CD4 T cell ratio differed between the two groups, being higher in CD patients mainly in the stromal area (Fig. 2b, middle panels and Fig. 2c). This evidence concerns the gene CD8A and neoplasm.